NSE: ANTELOPUS
ANTELOPUS SELAN ENRGY LTD
Price history
+36.96% over 3M
Performance
52-week range
Position in day range
ANTELOPUS stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹846.37
RSI (14)
85
Overbought zone
Volatility (ATR)
5.60%
High
Close streak
3d up
Volume vs 20d avg
0.94x
From 52W high
-7.73%
Up from 52W low
+214.87%
Green days (20)
11/20
Monthly seasonality
Average monthly move for ANTELOPUS across the available price history.
Key statistics
Open
1,160.3
Day high
1,169.9
Day low
1,090.5
Prev close
1,124.1
Volume
29.76 L
Avg vol (20d)
31.70 L
52W high
1,218.3
52W low
357
ANTELOPUS quarterly results
All ANTELOPUS results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹131 cr
+158.8% YoY
Net profit
₹54.32 cr
+384.1% YoY
Operating profit
₹81.63 cr
+565.3% YoY
EPS
₹15.45
+384.3% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹131 cr | ₹81.63 cr | ₹54.32 cr | 62.3% | 41.5% | ₹15.45 | +384.1% | +42.6% |
| Q4 FY262026-03-31 | ₹102 cr | ₹48.95 cr | ₹38.08 cr | 48.0% | 37.3% | ₹10.83 | — | +33.6% |
| Q3 FY262025-12-31 | ₹71.11 cr | ₹36.43 cr | ₹28.5 cr | 51.2% | 40.1% | ₹8.11 | — | +141.3% |
| Q2 FY262025-09-30 | ₹55.13 cr | ₹13.63 cr | ₹11.81 cr | 24.7% | 21.4% | ₹3.36 | — | +5.3% |
| Q1 FY262025-06-30 | ₹50.63 cr | ₹12.27 cr | ₹11.22 cr | 24.2% | 22.2% | ₹3.19 | — | — |
| TTM (last 4 quarters) | ₹359 cr | ₹181 cr | ₹133 cr | 50.3% | 36.9% | ₹37.75 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.